Inhibition of the interactions between metastatic human breast cancer cells and platelets by β-nitrostyrene derivatives

Life Sciences

Volumn 143, Issue , 2015, Pages 147-155

  Wei, Chien Kei ^a   Chang, Fang Rong ^a,b   Hsieh, Pei Wen ^c   Wu, Chin Chung ^a,d  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^d NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

Author keywords

Adhesion; Cancer; P selectin; Platelet aggregation; nitrostyrene

Indexed keywords

3,4 METHYLENE DIOXY BETA NITROSTYRENE; 4 O BENZOYL 3 METHOXYL BETA NITROSTYRENE; ACETYLSALICYLIC ACID; ANTIMETASTATIC AGENT; APYRASE; ARGINYLGLYCYLASPARTYLSERINE; PADGEM PROTEIN; PLATELET DERIVED GROWTH FACTOR; STYRENE DERIVATIVE; UNCLASSIFIED DRUG; ANTITHROMBOCYTIC AGENT; BETA-NITROSTYRENE;

ARTICLE; BREAST CANCER; CANCER CELL; CELL INTERACTION; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; METASTASIS INHIBITION; PROTEIN EXPRESSION; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOCYTE AGGREGATION INHIBITION; THROMBOCYTE RELEASE REACTION; TURBIDIMETRY; BREAST NEOPLASMS; CELL ADHESION; CELL SURVIVAL; CHEMISTRY; DOSE RESPONSE; DRUG EFFECTS; FEMALE; MCF 7 CELL LINE; METABOLISM; PHYSIOLOGY; THROMBOCYTE;

BLOOD PLATELETS; BREAST NEOPLASMS; CELL ADHESION; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MCF-7 CELLS; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; STYRENES;

EID: 84946828982     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2015.11.003     Document Type: Article

References (44)

1. C.S. Alves, M.M. Burdick, S.N. Thomas, P. Pawar, and K. Konstantopoulos The dual role of CD44 as a functional P-selectin ligand and fibrin receptor in colon carcinoma cell adhesion Am. J. Physiol. Cell Physiol. 294 2008 C907 C916
2. N.M. Bambace, and C.E. Holmes The platelet contribution to cancer progression J. Thromb. Haemost. 9 2011 237 249
3. M. Bartels, A.K. Calgarotto, A.C. Martens, V. Maso, S.L. da Silva, M.B. Bierings, and et al. Differential effects of nitrostyrene derivatives on myelopoiesis involve regulation of C/EBPalpha and p38MAPK activity PLoS ONE 9 2014 e90586
4. E. Bastida, G. Escolar, A. Ordinas, and G.A. Jamieson Morphometric evaluation of thrombogenesis by microvesicles from human tumor cell lines with thrombin-dependent (U87MG) and adenosine diphosphate-dependent (SKNMC) platelet-activating mechanisms J. Lab. Clin. Med. 108 1986 622 627
5. G. Bendas, and L. Borsig Cancer cell adhesion and metastasis: selectins, integrins, and the inhibitory potential of heparins Int. j.cell biol. 2012 2012 676731
6. L. Borsig, R. Wong, J. Feramisco, D.R. Nadeau, N.M. Varki, and A. Varki Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis Proc. Natl. Acad. Sci. U. S. A. 98 2001 3352 3357
7. H. Boukerche, O. Berthier-Vergnes, F. Penin, E. Tabone, G. Lizard, M. Bailly, and et al. Human melanoma cell lines differ in their capacity to release ADP and aggregate platelets Br. J. Haematol. 87 1994 763 772
8. L.F. Brass Thrombin and platelet activation Chest 124 2003 18S 25S
9. H.R. Buller, F.F. van Doormaal, G.L. van Sluis, and P.W. Kamphuisen Cancer and thrombosis: from molecular mechanisms to clinical presentations J. Thromb. Haemost. 5 Suppl 1 2007 246 254
10. A.K. Calgarotto, G.J. da Silva Pereira, A. Bechara, E.J. Paredes-Gamero, C.M. Barbosa, H. Hirata, and et al. Autophagy inhibited Ehrlich ascitic tumor cells apoptosis induced by the nitrostyrene derivative compounds: relationship with cytosolic calcium mobilization Eur. J. Pharmacol. 678 2012 6 14
11. Y. Cao Multifarious functions of PDGFs and PDGFRs in tumor growth and metastasis Trends Mol. Med. 19 2013 460 473
12. I.H. Chen, F.R. Chang, Y.C. Wu, P.H. Kung, and C.C. Wu 3,4-Methylenedioxy-beta-nitrostyrene inhibits adhesion and migration of human triple-negative breast cancer cells by suppressing beta1 integrin function and surface protein disulfide isomerase Biochimie 110 2015 81 92
13. P.H. Chen, X. Chen, and X. He Platelet-derived growth factors and their receptors: structural and functional perspectives Biochim. Biophys. Acta 1834 2013 2176 2186
14. L.A. Coupland, and C.R. Parish Platelets, selectins, and the control of tumor metastasis Semin. Oncol. 41 2014 422 434
15. B.F. de Souza, and P. Tricoci Novel anti-platelet agents: focus on thrombin receptor antagonists J. Cardiovasc. Transl. Res. 6 2013 415 424
16. J.W. Eikelboom, J. Hirsh, F.A. Spencer, T.P. Baglin, and J.I. Weitz Antiplatelet drugs: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines Chest 141 2012 e89S 119S
17. L.J. Gay, and B. Felding-Habermann Contribution of platelets to tumour metastasis Nat. Rev. Cancer 11 2011 123 134
18. A.M. Gil-Bernabe, S. Lucotti, and R.J. Muschel Coagulation and metastasis: what does the experimental literature tell us? Br. J. Haematol. 162 2013 433 441
19. H.A. Goubran, T. Burnouf, M. Radosevic, and M. El-Ekiaby The platelet-cancer loop Eur. J. Intern. Med. 24 2013 393 400
20. G. Grignani, L. Pacchiarini, P. Almasio, M. Pagliarino, G. Gamba, S.C. Rizzo, and et al. Characterization of the platelet-aggregating activity of cancer cells with different metastatic potential Int. j. cancer Journal int. du cancer. 38 1986 237 244
21. B. Ho-Tin-Noe, T. Goerge, S.M. Cifuni, D. Duerschmied, and D.D. Wagner Platelet granule secretion continuously prevents intratumor hemorrhage Cancer Res. 68 2008 6851 6858
22. P.W. Hsieh, Y.T. Chang, W.Y. Chuang, H.C. Shih, S.Z. Chiang, and C.C. Wu The synthesis and biologic evaluation of anti-platelet and cytotoxic beta-nitrostyrenes Bioorg. Med. Chem. 18 2010 7621 7627
23. J.H. Im, W. Fu, H. Wang, S.K. Bhatia, D.A. Hammer, M.A. Kowalska, and et al. Coagulation facilitates tumor cell spreading in the pulmonary vasculature during early metastatic colony formation Cancer Res. 64 2004 8613 8619
24. S. Jain, J. Harris, and J. Ware Platelets: linking hemostasis and cancer Arterioscler. Thromb. Vasc. Biol. 30 2010 2362 2367
25. P. Jurasz, G. Sawicki, M. Duszyk, J. Sawicka, C. Miranda, I. Mayers, and et al. Matrix metalloproteinase 2 in tumor cell-induced platelet aggregation: regulation by nitric oxide Cancer Res. 61 2001 376 382
26. J.H. Kim, J.H. Kim, G.E. Lee, J.E. Lee, and I.K. Chung Potent inhibition of human telomerase by nitrostyrene derivatives Mol. Pharmacol. 63 2003 1117 1124
27. Y.J. Kim, L. Borsig, N.M. Varki, and A. Varki P-selectin deficiency attenuates tumor growth and metastasis Proc. Natl. Acad. Sci. U. S. A. 95 1998 9325 9330
28. C. Medina, S. Harmon, I. Inkielewicz, M.J. Santos-Martinez, M. Jones, P. Cantwell, and et al. Differential inhibition of tumour cell-induced platelet aggregation by the nicotinate aspirin prodrug (ST0702) and aspirin Br. J. Pharmacol. 166 2012 938 949
29. S.A. Mousa, J. Bozarth, M. Forsythe, P. Tsao, L. Pease, and T.M. Reilly Role of platelet GpIIb/IIIa receptors in the modulation of platelet plasminogen activator inhibitors type-1 (PAI-1) release Life Sci. 54 1994 1155 1162
30. G.F. Nash, L.F. Turner, M.F. Scully, and A.K. Kakkar Platelets and cancer Lancet Oncol. 3 2002 425 430
31. T. Ogawa, A. Sugidachi, K. Otsuguro, T. Isobe, and F. Asai Platelet alpha-granule secretion and its modification by SC-57101A, a GPIIb/IIIa antagonist Biochem. Pharmacol. 63 2002 1911 1918
32. J.S. Palumbo, K.E. Talmage, J.V. Massari, C.M. La Jeunesse, M.J. Flick, K.W. Kombrinck, and et al. Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells Blood 105 2005 178 185
33. J. Park, and D. Pei Trans-beta-nitrostyrene derivatives as slow-binding inhibitors of protein tyrosine phosphatases Biochemistry 43 2004 15014 15021
34. Y. Rong, V.E. Belozerov, C. Tucker-Burden, G. Chen, D.L. Durden, J.J. Olson, and et al. Epidermal growth factor receptor and PTEN modulate tissue factor expression in glioblastoma through JunD/activator protein-1 transcriptional activity Cancer Res. 69 2009 2540 2549
35. Y. Rong, D.E. Post, R.O. Pieper, D.L. Durden, E.G. Van Meir, and D.J. Brat PTEN and hypoxia regulate tissue factor expression and plasma coagulation by glioblastoma Cancer Res. 65 2005 1406 1413
36. W. Ruf Tissue factor and cancer Thromb. Res. 130 Suppl 1 2012 S84 S87
37. W. Ruf, J. Disse, T.C. Carneiro-Lobo, N. Yokota, and F. Schaffner Tissue factor and cell signalling in cancer progression and thrombosis J. Thromb. Haemost. 9 Suppl 1 2011 306 315
38. Y.W. van den Berg, S. Osanto, P.H. Reitsma, and H.H. Versteeg The relationship between tissue factor and cancer progression: insights from bench and bedside Blood 119 2012 924 932
39. N. van Es, A. Sturk, S. Middeldorp, and R. Nieuwland Effects of cancer on platelets Semin. Oncol. 41 2014 311 318
40. W.Y. Wang, P.W. Hsieh, Y.C. Wu, and C.C. Wu Synthesis and pharmacological evaluation of novel beta-nitrostyrene derivatives as tyrosine kinase inhibitors with potent antiplatelet activity Biochem. Pharmacol. 74 2007 601 611
41. W.Y. Wang, Y.C. Wu, and C.C. Wu Prevention of platelet glycoprotein IIb/IIIa activation by 3,4-methylenedioxy-beta-nitrostyrene, a novel tyrosine kinase inhibitor Mol. Pharmacol. 70 2006 1380 1389
42. J.M. Werner, K. Eger, and S.H. Jurgen Comparison of the rapid pro-apoptotic effect of trans-beta-nitrostyrenes with delayed apoptosis induced by the standard agent 5-fluorouracil in colon cancer cells Apoptosis: an int. j. programmed cell death. 12 2007 235 246
43. C.C. Wu, and C.M. Teng Comparison of the effects of PAR1 antagonists, PAR4 antagonists, and their combinations on thrombin-induced human platelet activation Eur. J. Pharmacol. 546 2006 142 147
44. J.L. Yu, L. May, V. Lhotak, S. Shahrzad, S. Shirasawa, J.I. Weitz, and et al. Oncogenic events regulate tissue factor expression in colorectal cancer cells: implications for tumor progression and angiogenesis Blood 105 2005 1734 1741